Related Experiment Videos
Community acquired and post-transfusion hepatitis C "is there a difference?"
A R Qureshi1, S Hamid, W Jafri
1Department of Medicine, Aga Khan University Hospital, Karachi.
JPMA. the Journal of the Pakistan Medical Association
|January 1, 1996
Summary
Community-acquired (CA) and post-transfusion (PT) hepatitis C share similar lab and histology findings. However, CA hepatitis C is more common in males, while PT hepatitis C affects more females.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection can be acquired through community exposure or blood transfusions.
- Distinguishing between community-acquired (CA) and post-transfusion (PT) hepatitis C is crucial for understanding transmission routes and patient demographics.
Purpose of the Study:
- To compare the epidemiological, laboratory, and histological characteristics of community-acquired (CA) and post-transfusion (PT) hepatitis C.
- To identify potential differences in disease presentation and progression between the two groups.
Main Methods:
- Retrospective analysis of 77 hepatitis C antibody-positive patients.
- Comparison of patient history, laboratory data, and liver biopsy findings between CA and PT hepatitis C groups.
- Statistical analysis of demographic data, including age, sex, and time to presentation.
Main Results:
- No significant differences were observed in mean age, laboratory parameters, or histological disease activity scores between CA and PT hepatitis C groups.
- The male to female ratio was 2:1 in the CA group versus 1:2.4 in the PT group.
- Cirrhosis with chronic active hepatitis (CAH) was more prevalent in the CA group (68%) compared to the PT group (54%).
Conclusions:
- Hepatitis C is a significant cause of community-acquired hepatitis.
- Post-transfusion hepatitis C is more common in females, potentially due to transfusion history related to obstetric and gynecological reasons.
- Laboratory and histological features of hepatitis C do not significantly differ between community-acquired and post-transfusion cases.